Citation Impact
Citing Papers
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic
2009 StandoutNature
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
2001
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
2009
Scaffolds in tissue engineering bone and cartilage
2000 Standout
Emerging Infections: Pandemic Influenza
1996
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Bone substitutes: An update
2005 Standout
Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness
2008 Standout
The history of simian AIDS
1996
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
2009
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Engineering of Cartilage Tissue Using Bioresorbable Polymer Fleeces and Perfusion Culture
1995
Prevention of Systemic Infections Caused by Group B Streptococcus and Staphylococcus aureus by Multivalent Polysaccharide‐Protein Conjugate Vaccines
1995
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
2007
Cartilage reconstruction in head and neck surgery: Comparison of resorbable polymer scaffolds for tissue engineering of human septal cartilage
1998
The development of vaccines: how the past led to the future
2011
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
1994 Standout
Production of Macrophage Migration Inhibition Factors by Virus-Infected Cell Cultures
1973 StandoutNobel
Do Postcard Reminders Improve Influenza Vaccination Compliance?
1982
The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine
1978
Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of epstein‐barr virus dna as those found in tumor cells
1977 StandoutNobel
PREDETERMINATION BY INFECTION AND BY VACCINATION OF ANTIBODY RESPONSE TO INFLUENZA VIRUS VACCINES
1957
Sites of sequence variability in Epstein-Barr virus DNA from different sources.
1979 StandoutNobel
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
Summary of Clinical Trials of Inactivated Influenza Vaccine--1978
1983
Characterization of the DNA of a defective human parvovirus isolated from a genital site
1984 StandoutNobel
Cross‐protection and cross‐reactive cytotoxic T cells induced by influenza virus vaccines in mice
1980
Human Adeno-Associated Virus Type 5 Is Only Distantly Related to Other Known Primate Helper-Dependent Parvoviruses
1999 StandoutNobel
Pneumonia Complicating Asian Influenza
1958
Virus of the 1918 Influenza Pandemic Era: New Evidence about Its Antigenic Character
1969 StandoutScienceNobel
Immunity to Mumps in an Institutional Epidemic. Correlation of Insusceptibility to Mumps with Serum Plaque Neutralizing and Hemagglutination-inhibiting Antibodies
1969
Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications
1983 Standout
DISQUISITIONS ON ORIGINAL ANTIGENIC SIN
1966 Standout
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
2009 Standout
A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells
1976 Standout
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
1976 StandoutScience
Evolution and ecology of influenza A viruses
1992 Standout
Plaque Formation by Mumps Virus and Inhibition by Antiserum
1970
Immunogenicity and Reactogenicity of Influenza A/New Jersey/76 Virus Vaccines in Normal Adults
1977
Capacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populations
1982 StandoutNobel
Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions
1998 Standout
Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non‐tumorous tissues of chinese patients with special reference to lymphoblastoid transformation
1970
Central nervous system syndromes of “viral” etiology
1960
Main properties and current applications of some polysaccharides as biomaterials
2007 Standout
Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.
1971
Continuous Lymphoid Cell Lines with Characteristics of B Cells (Bone-Marrow-Derived), Lacking the Epstein-Barr Virus Genome and Derived from Three Human Lymphomas
1974 StandoutNobel
Adenovirus-Associated Defective Virus Particles
1965 StandoutScience
Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the Nasopharynx
1974 StandoutNobel
Distribution and Significance of Asian and Other Influenza Antibodies in the Human Population
1958
Cultured human lymphocytes
1972
ACTION OF ENDOGENOUS INTERFERON AGAINST VACCINIA INFECTION IN CHILDREN
1965
The Health Belief Model: A Decade Later
1984 Standout
Transmission of disease through transplantation of musculoskeletal allografts.
1995
Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease
1998 StandoutNobel
THE IDENTIFICATION AND SOURCES OF MYCOPLASMAS ISOLATED FROM CONTAMINATED CELL CULTURES
1973
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
2002 Standout
Asian Influenza A in Boston. 1957-1958
1959
Persistence of Hong Kong Influenza Virus Variants in Pigs
1977 Science
Pathogenesis of Dengue: Challenges to Molecular Biology
1988 StandoutScience
Correlates of Protection Induced by Vaccination
2010 Standout
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of H. M. Meyer being referenced
In-vitro-Untersuchungen zur möglichen Übertragung des humanen Immundefizienz Virus (HIV) durch allogene Knorpeltransplantate
1993
Human Immunodeficiency Virus Cannot Productively Infect Freshly Cultured Human Cartilage Cells
1993
A Status Report on National Immunization against Influenza
1976
Rhesus Leukocyte-associated Herpesvirus, II. Natural and Experimental Infection
1973
Lymphoblastoid Cell Cultures from Patients with Infectious Hepatitis
1969
Metabolic Inhibition Test for Determination of Antibodies to Group B Coxsackie Viruses.
1958
New Antigenic Variant in Far East Influenza Epidemic, 1957
1957
Summary of Clinical Trials of Influenza Virus Vaccines in Adults
1977
Rubella vaccination. A review of practical experience
1971
A Plaque Neutralization Test for Determining Mumps Antibodies
1968
Titration of Live Measles and Smallpox Vaccines by Jet Inoculation of Susceptible Children
1965
Antibody in Hepatitis Patients Against a Newly Isolated Virus
1961